Plasma viscosity as a cardiovascular risk marker in patients with proteinuria

Clinical Hemorheology and Microcirculation

Volumn 29, Issue 2, 2003, Pages 111-116

  Ercan, M ^a,b   Konukoglu, D ^a   Onen, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Department of Biochemistry ^*  (Turkey)

Author keywords

Cardiovascular risk; Plasma viscosity; Proteinuria

Indexed keywords

ALBUMIN; CREATININE; ENZYME; FIBRINOGEN; PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CAPILLARY; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMMERCIAL PHENOMENA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LOW GRADE NEPHROTIC PROTEINURIA; MALE; MEASUREMENT; MULTIPLE REGRESSION; PATIENT; PLASMA VISCOSITY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEINURIA; TRIACYLGLYCEROL BLOOD LEVEL; VISCOMETER;

ADULT; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD VISCOSITY; CAPILLARIES; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; PLASMA; PROTEINURIA; REFERENCE VALUES; RISK FACTORS;

EID: 0344441947     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. G. Mchedlishvili, Disturbed blood flow structuring as critical factor of hemorheological disorder in microcirculation, Clin. Hemorheol. Microcirc. 19(4) (1998), 15-25.
2. B. Friesenecker, M. McCarthy, H. Sakai, J.H. Barbee and G.R Cokelet, The Fahraeus effect, Microvasc. Res. 3 (1971), 6-16.
3. J. Koscielny, H. Kiesetter, F. Jung, H. Radtke, A. Birk and A. Moll, The choice of treatment in arterial occlusive disease and hemorheologic diasturbances, Cardiovasc. Risk Factors 5 (1996), 281-289.
4. F. Jung, G. Pindur and H. Kiesewetter, Plasma viscosity dependence on proteins and lipoproteins: Results of the Aachen-Study, Clin. Hemorheol. 12 (1992), 557-571.
5. D. Eterovic, I. Pintaric, J. Tocily and Z. Reiner, Determinants of plasma viscosity in primary hyperlipoproteinemias, Clin. Hemorheol. 15 (1995), 841-850.
6. J. Joven, X. Cliville, J. Camps, E. Espinel, J. Simo, E. Vilella and A. Oliver, Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity, Clin. Chem. 43(7) (1997), 1223-1231.
7. S. Sahu, K. Nageswari, R. Banerjee and R.R. Puniyani, Hemorheological changes in nephrotic syndrome, Clin. Hemorheol. Microcirc. 19 (1998), 17-20.
8. E. Oviasu, A.A. Famodu and E.A. Ojeh, Plasma viscosity in nephrotic Nigerians, Clin. Hemorheol. Microcirc. 19 (1998), 163-167.
9. G.M. London, S.J. Marchais, F. Metivier and A.P. Guerin, Cardiovascular risk in end-stage renal disease: vascular aspects, Neophrol. Dial. Transplant 15(Suppl. 5) (2000), 97-104.
10. J.D. Ordonez, R.A. Hiatt, E.J. Killebrew and B.H. Fireman, The increased risk of coronary heart disease associated with the nephrotic syndrome, Kidney Int. 44 (1993), 638-642.
11. W. Koenig, M. Sund, H. Löwel, A. Döring and E. Ernst, Association between plasma viscosity and all cause mortality: results from Monica-Ausburg Cohort Study, 1984-1992, Brit. J. Hematol. 109 (2000), 453-458.
12. International Committee for standardization in hematology expert panel on blood rheology, Guidelines for measurement of blood viscosity and erythrocyte deformability, Clin. Hemorheol. Microcirc. 6 (1986), 539-553.
13. J. Harkness, A new method for the measurement of plasma viscosity, Lancet 2 (1963), 280.
14. J.W. Yarnell, I.A. Baker, P.M. Sweetnam, D. Bainton, J.R. O'Brien, P.J. Whitehead and P.C. Elwood, Fibrinogen viscosity and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 83 (1991), 836-844.
15. W. Koenig, M. Sund, E. Ernst, U. Keil, J. Rosenthal and V. Hombach, Association between plasma viscosity and blood pressure. Results from the Monica-project Ausburg, Am. J. Hypertens. 4(6) (1991), 529-536.
16. Y. Tomiyama, J.E. Brian Jr. and M.M. Todd, Plasma viscosity and cerebral blood flow, Am. J. Physiol. (Heart Circ. Physiol.) 279 (2000), H1949-H1954.
17. C.J. Deighan, M.J. Caslake, M. Mc Connel, M. Boulton-Jones and C.J. Packard, Increased atherogenicity of low-density lipoprotein in heavy proteinuria, Nephrol. Dial. Transplant 13 (1998), 1183-1188.
18. M. Zanetti, R. Barazzoni, G. Garibotto, G. Davanzo, C. Gabelli, E. Kiwanuka, A. Piccoli, M. Tosolini and P. Tessari, Plasma protein synthesis in patients with low-grade nephrotic proteinuria, Am. J. Physiol. (Endocrinol. Metab.) 280 (2001), E591-E597.
19. M.P. Gordge, R.W. Faint, P.B. Rylance and G.H. Neild, Abnormal blood rheology in proggessive renal failure: a factor in non-immune glomerular injury?, Nephrol. Dial. Transplant 3(3) (1988), 257-262.
20. W.H. Frishman, Biologic markers as predictors of cardiovascular disease, Am. J. Med. 104 (1998), 185-275.